Ashkenazi A - Search Results

1

Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display.

Nair PM, Flores H, Gogineni A, Marsters S, Lawrence DA, Kelley RF, Ngu H, Sagolla M, Komuves L, Bourgon R, Settleman J, Ashkenazi A. Nair PM, et al. Among authors: ashkenazi a. Proc Natl Acad Sci U S A. 2015 May 5;112(18):5679-84. doi: 10.1073/pnas.1418962112. Epub 2015 Apr 20. Proc Natl Acad Sci U S A. 2015. PMID: 25902490 Free PMC article.

2

Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding.

Marsters SA, Frutkin AD, Simpson NJ, Fendly BM, Ashkenazi A. Marsters SA, et al. Among authors: ashkenazi a. J Biol Chem. 1992 Mar 25;267(9):5747-50. J Biol Chem. 1992. PMID: 1313418 Free article.

3

A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors.

Oksenberg D, Marsters SA, O'Dowd BF, Jin H, Havlik S, Peroutka SJ, Ashkenazi A. Oksenberg D, et al. Among authors: ashkenazi a. Nature. 1992 Nov 12;360(6400):161-3. doi: 10.1038/360161a0. Nature. 1992. PMID: 1436092

4

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, Goeddel DV, Palladino MA, Smith DH. Ashkenazi A, et al. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10535-9. doi: 10.1073/pnas.88.23.10535. Proc Natl Acad Sci U S A. 1991. PMID: 1660140 Free PMC article.

5

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity.

Ashkenazi A, Smith DH, Marsters SA, Riddle L, Gregory TJ, Ho DD, Capon DJ. Ashkenazi A, et al. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7056-60. doi: 10.1073/pnas.88.16.7056. Proc Natl Acad Sci U S A. 1991. PMID: 1871120 Free PMC article.

6

Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.

Ashkenazi A, Presta LG, Marsters SA, Camerato TR, Rosenthal KA, Fendly BM, Capon DJ. Ashkenazi A, et al. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7150-4. doi: 10.1073/pnas.87.18.7150. Proc Natl Acad Sci U S A. 1990. PMID: 2402498 Free PMC article.

7

Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.

Jin H, Yang R, Marsters S, Ashkenazi A, Bunting S, Marra MN, Scott RW, Baker JB. Jin H, et al. Among authors: ashkenazi a. J Clin Invest. 1995 Apr;95(4):1947-52. doi: 10.1172/JCI117877. J Clin Invest. 1995. PMID: 7706502 Free PMC article.

8

Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain.

Marsters SA, Pennica D, Bach E, Schreiber RD, Ashkenazi A. Marsters SA, et al. Among authors: ashkenazi a. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5401-5. doi: 10.1073/pnas.92.12.5401. Proc Natl Acad Sci U S A. 1995. PMID: 7777519 Free PMC article.

9

A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.

Chamow SM, Zhang DZ, Tan XY, Mhatre SM, Marsters SA, Peers DH, Byrn RA, Ashkenazi A, Junghans RP. Chamow SM, et al. Among authors: ashkenazi a. J Immunol. 1994 Nov 1;153(9):4268-80. J Immunol. 1994. PMID: 7930627

10

Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody.

Jin H, Yang R, Marsters SA, Bunting SA, Wurm FM, Chamow SM, Ashkenazi A. Jin H, et al. Among authors: ashkenazi a. J Infect Dis. 1994 Nov;170(5):1323-6. doi: 10.1093/infdis/170.5.1323. J Infect Dis. 1994. PMID: 7963738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

561 results

Search Page

Filters